STTK 1 (-0.99%)
US82024L1035BiotechnologyBiotechnology

Shattuck Labs (STTK) Stock Highlights

1 | -0.99%
2024-11-23 06:19:03
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

Statistics

Range Today
0.94 1.02
Volume Today 395K
Range 1 Year
0.99 11.76
Volume 1 Year 194.42M
Range 3 Year
0.99 11.76
Volume 3 Year 252.95M
Range 10 Year
0.99 60.52
Volume 10 Year 314.47M

Highlights

Market Capitalization 56.32M (small)
Floating Shares 27.69M
Current Price 1
Price To Earnings -0.71
Price To Revenue -10.96
Price To Book 0.51
Earnings Per Share -1.76
Payout Ratio 0%

Performance

Latest -0.99%
1 Month -20%
3 Months -70.85%
6 Months -86.82%
1 Year -55.56%
3 Years -89.41%
5 Years -95.45%
10 Years -95.45%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.